About Repligen
Repligen is a company based in Bridgewater (United States) founded in 1985 was acquired by Repligen in April 2019. It operates as a Professional Services, and Direct-to-Consumer (D2C). Repligen offers products and services including Process Analytical Technology (PAT), XCell ATF Systems, KrosFlo TFF Systems, and OPUS Pre-packed Columns.
- Headquarter Bridgewater, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Repligen Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Repligen
Repligen offers a comprehensive portfolio of products and services, including Process Analytical Technology (PAT), XCell ATF Systems, KrosFlo TFF Systems, and OPUS Pre-packed Columns. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Solutions for real-time bioprocessing monitoring are provided.
Filtration systems for upstream bioprocessing are offered.
Tangential flow filtration systems are designed for bioprocessing.
Pre-packed chromatography columns for purification are supplied.
Funding Insights of Repligen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Repligen
Repligen has secured backing from 1 investor. Prominent investors backing the company include Repligen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Products and services for biologic drug manufacturing are supplied.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Repligen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Repligen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Repligen Comparisons
Competitors of Repligen
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Repligen
When was Repligen founded?
Repligen was founded in 1985.
Where is Repligen located?
Repligen is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
What does Repligen do?
Repligen is involved in the development and supply of advanced bioprocessing technologies. Solutions are offered for upstream and downstream processes, including process analytical technology (PAT), filtration systems, chromatography, and fluid management. The company serves sectors such as gene therapy, cell therapy, and biologics, supporting therapeutic innovation. Real-time monitoring and optimization tools are provided to enhance manufacturing efficiency and ensure product quality across various modalities like antibodies, viral vectors, and mRNA.
What products or services does Repligen offer?
Repligen offers Process Analytical Technology (PAT), XCell ATF Systems, KrosFlo TFF Systems, and OPUS Pre-packed Columns.
Who are Repligen's investors?
Repligen has 1 investor. Key investors include Repligen.